Failure to Target RANKL Signaling Through p38-MAPK Results in Defective Osteoclastogenesis in the Microphthalmia Cloudy-Eyed Mutant

Journal of Cellular Physiology

Volumn 231, Issue 3, 2016, Pages 630-640

  Carey, Heather A ^a   Bronisz, Agnieszka ^b   Cabrera, Jennifer ^a   Hildreth, Blake E ^a,c   Cuitiño, Maria ^a   Fu, Qi ^a   Ahmad, Asrar ^a   Toribio, Ramiro E ^c   Ostrowski, Michael C ^a,d   Sharma, Sudarshana M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 14; OSTEOCLAST DIFFERENTIATION FACTOR; MITF PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IN VITRO STUDY; MALE; MICROPHTHALMIA; MOLECULAR DOCKING; MOUSE; MYELOID PROGENITOR CELL; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; MAP KINASE SIGNALING SYSTEM; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MICROPHTHALMOS; MUTATION; OSTEOCLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANK LIGAND;

EID: 84949033160     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25108     Document Type: Article

References (36)

1. Bardwell AJ, Frankson E, Bardwell L. 2009. Selectivity of docking sites in MAPK kinases. J Biol Chem 284:13165-13173.
2. Boyle WJ, Simonet WS, Lacey DL. 2003. Osteoclast differentiation and activation. Nature 423:337-342.
3. Bronisz A, Carey HA, Godlewski J, Sif S, Ostrowski MC, Sharma SM. 2014. The multifunctional protein fused in sarcoma (FUS) is a coactivator of microphthalmia-associated transcription factor (MITF). J Biol Chem 289:326-334.
4. Chen M, Qiao H, Su Z, Li H, Ping Q, Zong L. 2014. Emerging therapeutic targets for osteoporosis treatment. Expert Opin Ther Targets 18:817-831.
5. Cielinski MJ, Marks SC. 1994. Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib). Bone 15:707-715.
6. Deshaies RJ, Ferrell JE, Jr. 2001. Multisite phosphorylation and the countdown to S phase. Cell 107:819-822.
7. Garai A, Zeke A, Gogl G, Toro I, Fordos F, Blankenburg H, Barkai T, Varga J, Alexa A, Emig D, Albrecht M, Remenyi A. 2012. Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci Signal 5:ra 74.
8. Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA, Fisher DE. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:2770-2780.
9. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, Arnheiter H. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395-404.
10. Hu R, Sharma SM, Bronisz A, Srinivasan R, Sankar U, Ostrowski MC. 2007. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol Cell Biol 27:4018-4027.
11. Ikeda K, Takeshita S. 2014. Factors and mechanisms involved in the coupling from bone resorption to formation: How osteoclasts talk to osteoblasts. J Bone Metab 21:163-167.
12. Kikuta J, Ishii M. 2013. Osteoclast migration, differentiation and function: Novel therapeutic targets for rheumatic diseases. Rheumatology 52:226-234.
13. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
14. Levy C, Khaled M, Fisher DE. 2006. MITF: Master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:406-414.
15. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
16. Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, Ostrowski MC. 2001. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 276:36703-36710.
17. Luo RX, Postigo AA, Dean DC. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
18. Mansky KC, Sankar U, Han J, Ostrowski MC. 2002. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kB ligand signaling. J Biol Chem 277:11077-11083.
19. Meadows NA, Sharma SM, Faulkner GJ, Ostrowski MC, Hume DA, Cassady AI. 2007. The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J Biol Chem 282:1891-1904.
20. Molina DM, Grewal S, Bardwell L. 2005. Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation. J Biol Chem 280:42051-42060.
21. Moore KJ. 1995. Insight into the microphthalmia gene. Trends in genetics: TIG 11:442-448.
22. Morii E, Ogihara H, Kim DK, Ito A, Oboki K, Lee YM, Jippo T, Nomura S, Maeyama K, Lamoreux ML, Kitamura Y. 2001. Importance of leucine zipper domain of mi transcription factor (MITF) for differentiation of mast cells demonstrated using mi(ce)/mi(ce) mutant mice of which MITF lacks the zipper domain. Blood 97:2038-2044.
23. Novack DV, Teitelbaum SL. 2008. The osteoclast: Friend or foe?. Annual review of pathology 3:457-484.
24. Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S, Ostrowski MC. 2007. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem 282:15921-15929.
25. Sharma SM, Sif S, Ostrowski MC, Sankar U. 2009. Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice. J Cell Physiol 220:230-237.
26. Shen YH, Godlewski J, Bronisz A, Zhu J, Comb MJ, Avruch J, Tzivion G. 2003. Significance of 14- 3-3 self-dimerization for phosphorylation-dependent target binding. Mol Biol Cell 14:4721-4733.
27. So H, Rho J, Jeong D, Park R, Fisher DE, Ostrowski MC, Choi Y, Kim N. 2003. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor osteoclast-associated receptor gene expression. J Biol Chem 278:24209-24216.
28. Steingrimsson E, Moore KJ, Lamoreux ML, Ferre-D'Amare AR, Burley SK, Zimring DC, Skow LC, Hodgkinson CA, Arnheiter H, Copeland NG, et al. 1994. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 8:256-263.
29. Sweeney SE, Firestein GS. 2006. Mitogen activated protein kinase inhibitors: where are we now and where are we going? Anno Rheum Dis 65: iii83-88.
30. Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
31. Tshori S, Gilon D, Beeri R, Nechushtan H, Kaluzhny D, Pikarsky E, Razin E. 2006. Transcription factor MITF regulates cardiac growth and hypertrophy. J Clin Invest 116:2673-2681.
32. Ubersax JA, Ferrell JE, Jr. 2007. Mechanisms of specificity in protein phosphorylation. Nat Rev Molcell Biol 8:530-541.
33. Weilbaecher KN, Hershey CL, Takemoto CM, Horstmann MA, Hemesath TJ, Tashjian AH, Fisher DE. 1998. Age-resolving osteopetrosis: A rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med 187:775-785.
34. Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, Fisher DZ, Fisher DE. 2000. C-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14:301-312.
35. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442-444.
36. Zimring DC, Lamoreux ML, Millichamp NJ, Skow LC. 1996. Microphthalmia cloudy-eye (mi(ce)): A new murine allele. J Hered 87:334-338.